3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
64
Breast Neoplasms
20
Kidney Neoplasms
19
Gastrointestinal Stromal Tumors
16
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
9
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Brain Neoplasms
7
Colorectal Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Thyroid Neoplasms
4
Stomach Neoplasms
4
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Thyroid Cancer, Papillary
3
Sarcoma
3
Pancreatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Kidney Diseases
3
Glioblastoma
3
Esophageal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Astrocytoma
3
Adenoma, Islet Cell
3
Adenocarcinoma, Follicular
3
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Sunitinib
×
Clear all
No trials found.